Latest news for West Vault Mining (OTC:WVMDF) Stock

West Vault Mining Inc is a Canada-based exploration and development company working on mineral properties. The Company has precious metals mineral position in the Walker Lane gold trend in Southern Nevada. The company's asset is the Hasbrouck Project, which is located between Reno and Las Vegas, near the town of Tonopah, Nevada and it consists of approximately two deposits, the Hasbrouck deposit, and the Three Hills properties.

WEST VAULT MINING INC. by West Vault Mining Inc.

West Vault Mining Inc

Truist Securities analyst Michael Ciarmoli maintains Moog (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOG#NYSE">MOG</a>) with a Buy and raises the price target from $224 to $237.

News

Price Target

Analyst Ratings

MOG/A

Truist Securities Maintains Buy on Moog, Raises Price Target to $237

&#8220;I&#8217;ve always been an adventure seeker,&#8221; says Cort Smith.
Those words encapsulate the driving force behind a career that thrives on calculated risks and breakthrough developments. As the founder of Synergy Innovation, the parent company of DaVinci Vaporizers and Eyce, Smith has channeled his passion for precision and problem-solving into reshaping the cannabis accessories market. DaVinci's vaporizers have become synonymous with meticulous engineering for connoisseurs, while Eyce is renowned for its nearly indestructible gear, designed for the adventurous spirit. Together, these brands reflect Smith's commitment to blending innovation, functionality and durability.
Sitting down at MJBizCon in Las Vegas, Smith's energy is palpable as he recounts how his unconventional journey unfolded. From building bungee jumping equipment in China to creating one of the world's most trusted cannabis vaporizer brands, Smith&#8217;s story is one of bold decisions and unrelenting dedication to quality.
"I was in an economics class in the 80s," he begins, "and someone mentioned China. They said, ‘In the next 30 years, it's going to become one of the top five economies in the world.'" At a time when Japan dominated discussions of global opportunity, Smith saw potential elsewhere. "I thought, ‘I'm going to miss that boat,'" he told Benzinga, referencing Japan's popularity among aspiring entrepreneurs. "But no one was talking about China yet." Recognizing the untapped possibilities, Smith began learning Mandarin and preparing for a future in a country few Westerners dared to explore.
<h2 class="wp-block-heading">How A Leap Of Faith Built A Brand</h2>
Smith's entrepreneurial debut was as unconventional as it was audacious: launching a bungee jumping business in China. "I was producing my own bungee cords, equipment and towers—all in China," he recalls. "I thought it'd be a one-or-two-year stepping stone to figure out what else a foreigner could do there."
But what started as a short-term venture quickly became a pivotal chapter in his life. "That business turned into a PhD-level education in negotiating with factories, contracting and building something where safety is critical," he says. Managing the intricacies of a high-risk operation in an unfamiliar market demanded precision, adaptability and resilience, skills that would later become hallmarks of Smith's approach to manufacturing.
See also: <a href="https://www.benzinga.com/markets/cannabis/25/01/42962940/this-is-how-you-make-quality-joints-how-one-machine-produces-900-pre-rolls-an-hour-and-why-theyre-better-than-cones">&#8216;This Is How You Make Quality Joints&#8217; &#8211; How One Machine Produces 900 Pre-Rolls An Hour And Why They&#8217;re Better Than Cones</a>
After five years in the bungee business, Smith shifted gears, applying his expertise to a broader range of manufacturing projects. "Other people started coming to me, saying, ‘Hey, I want to build something,'" he says. From producing massive banners for NASCAR to managing custom projects, Smith honed his ability to guide complex manufacturing processes. "I realized how much detail was needed to babysit these processes."
This phase of his career ultimately introduced him to the burgeoning e-cigarette industry. While the work refined his design and manufacturing skills, Smith found little personal fulfillment in the sector. "I wasn't a tobacco guy," he admits. "I didn't get to control the product. It was just receiving goods from China and helping sell them."
<h2 class="wp-block-heading">The Birth Of DaVinci Vaporizers</h2>
The turning point came in 2011 when Smith envisioned a new direction: cannabis vaporizers. He recalls telling his partner, "You're building something with a battery that gets hot for human ingestion. Why don't we spin this for cannabis?" The concept resonated deeply and DaVinci Vaporizers was born.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/14100500/DaVinci-Phone-Connectivity-1024x683.jpg" alt="DaVinci Vaporizer" class="wp-image-732682" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/14100500/DaVinci-Phone-Connectivity-1024x683.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/14100500/DaVinci-Phone-Connectivity-300x200.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/14100500/DaVinci-Phone-Connectivity-768x512.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/14100500/DaVinci-Phone-Connectivity-1536x1025.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/14100500/DaVinci-Phone-Connectivity.jpg 1619w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Smith's personal experiences with cannabis fueled his drive to innovate. "I'd go to a buddy's house, crack a few beers, smoke a few bowls and end up with these terrible tension headaches," he says. A chance encounter with a vaporizer at a cannabis expo shifted his perspective. "It wasn't great, but I noticed I didn't get the same headaches. I thought, ‘I can build something better.'"
With DaVinci, Smith set out to create the cleanest, most reliable vaporizer on the market. "No lead soldering, no off-gassing from cheap plastics," he explains. His vision was simple yet ambitious: design a device that prioritized safety and performance above all. This philosophy laid the foundation for DaVinci's signature features, such as ceramic heating bowls that maintain stable temperatures for consistent, high-quality vapor.
<h2 class="wp-block-heading">A Global Fanbase</h2>
The reputation of DaVinci Vaporizers isn't solely built on the quality of its devices. It's also shaped by Smith's deliberate global approach to the cannabis accessories market, a vision that extended well beyond North America. While many companies prioritized the domestic market, Smith recognized the potential of international opportunities early on. "We were early to go to the trade shows overseas and connect with international customers," he says, describing how these connections helped DaVinci gain traction across Europe and other regions.
Smith's appreciation for constant refinement found inspiration in an unlikely place: the workshops of Leonardo da Vinci himself. "I visited his old homes and saw his work firsthand," Smith shares. "It gave me the mindset to keep refining, to never stop improving." That relentless drive to perfect his craft resonated with a worldwide audience and helped cement DaVinci's reputation for reliability and innovation.
Unlike many cannabis brands that struggle to gain recognition outside their home markets, DaVinci stands out as a trusted name among cannabis enthusiasts globally. Similar to brands like RAW Rolling Papers and OCB Rolling Papers, DaVinci has achieved an exceptional level of recognition by maintaining its focus on high-quality vaporizers for discerning consumers. While Smith's scope remains focused on creating premium devices, DaVinci's ability to connect with a global audience is a testament to the brand's dedication to quality and precision.
<h2 class="wp-block-heading">Innovation Beyond Vaporizers</h2>
Smith's drive for innovation doesn't stop with vaporizers. Under Synergy Innovation's umbrella is Eyce, a brand known for its rugged, high-performance smoking accessories that are nearly indestructible. "Eyce is the best in class for durability," Smith explains. Designed for an active lifestyle, Eyce products pair silicone exteriors with glass inserts, offering users the purity of glass combined with unmatched resilience.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="760" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/14100515/Eyce-Spoon-Group-1024x760.jpg" alt="Eyce Pipe" class="wp-image-732686" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/14100515/Eyce-Spoon-Group-1024x760.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/14100515/Eyce-Spoon-Group-300x223.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/14100515/Eyce-Spoon-Group-768x570.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/14100515/Eyce-Spoon-Group.jpg 1455w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Smith himself is a dedicated fan. "My daily go-to is an Eyce product," he says, noting the practicality of its design. "It's rugged enough that my dog can chew on it, or I can toss it in a backpack. It's a product that just works, no matter where you are." With its lifetime guarantee and appeal to adventurous users, Eyce has carved out its own niche in the cannabis accessories market, standing alongside DaVinci in customer loyalty and trust.
This dual-pronged approach &#8211; DaVinci for precision and sophistication and Eyce for durability and practicality &#8211; highlights Synergy Innovation's ability to cater to diverse consumer needs. "We're not trying to be everything to everyone," Smith explains. "We focus on building the best products for the people who care about quality, whether it's a rugged Eyce piece for the outdoors or a DaVinci vaporizer for precision enthusiasts."
<h2 class="wp-block-heading">Balancing Innovation And Authenticity</h2>
Smith's commitment to quality extends far beyond his products; it's a cornerstone of the culture at Synergy Innovation. The company embodies a work-hard, play-hard ethos where team outings often double as creative brainstorming sessions. "We're in the green industry, so why not be edgy?" Smith says with a smile. "We don't follow the norms. We see our colleagues more than we see our families, so we try to make it feel like family."
This collaborative and adventurous spirit fuels creativity and ensures the products stay aligned with their mission of authenticity. For Smith, maintaining a sense of fun and passion is just as important as the technical precision that defines Synergy Innovation's products. "It's about more than just work," he says. "When you love what you do, it shows in the products you create."
Looking ahead, Smith is determined to continue innovating without compromising his values. With new products and technologies already in the pipeline, Synergy Innovation is set to build on the legacy of precision, durability and quality that DaVinci and Eyce have established. For Smith and his team, the mission is clear: create industry-leading products that elevate the cannabis experience for consumers worldwide.
Photos courtesy of Synergy Innovation

Cannabis

Success Stories

Exclusives

Interview

Leonardo DaVinci Meets Bungee Jumping: The Curious Origins A World-Leading Cannabis Vaporization Brand

WIIM

Emcor shares are trading higher after the company announced it will acquire Miller Electric for $865 million in an all-cash deal.

Wells Fargo analyst Ken Gawrelski maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Equal-Weight and raises the price target from $197 to $212.

AMZN

Wells Fargo Maintains Equal-Weight on Amazon.com, Raises Price Target to $212

No one could accuse the late former President Jimmy Carter of hoarding fortunes in murky trusts and eliciting favors from lobbyists and foreign governments. The famously devout Christian – as profiled here in The New York Times – spent the last 43 years of his life living in a modest four-bedroom ranch house in rural <a href="https://www.benzinga.com/news/23/08/33600052/jimmy-carter-the-oldest-living-president-redefines-hospice-care-with-his-95-year-old-wife-as-they-en">Plains, Georgia</a>, assessed most recently for $167,066 according to public property records, as revealed by<a href="https://www.cnbc.com/2025/01/08/jimmy-carter-spent-last-decades-in-inexpensive-house-he-built-himself.html"> CNBC</a>. Even at the current Zillow assessment of $247,100, the home is well below the website&#8217;s median for the state of $326,280.
Don't Miss:
<ul>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
<h2 class="wp-block-heading">A Prolific Writer</h2>
A prolific writer, Carter made the majority of his money post-presidency from writing books – in all, 66 bear his name, according to Thrifbooks.com. However, People puts the number of books he authored at 32, with many of them bestsellers. He wrote on diverse topics, including faith and foreign and domestic policy, which allowed him to go on book and speaking tours. However, according to The Independent, he reportedly rejected many of the engagements he was offered – often a lucrative source of income for many other former presidents. Unlike them, however, Carter did not charge big speaking fees and donated much of the money he received to charity. In addition, he often flew on commercial flights, shaking hands with passengers as he took his seat, as this video on People shows.
&#8220;I&#8217;ve never criticized what Presidents Nixon, Ford or Reagan do with their post-White House years,&#8221; Carter told The Los Angeles Times. &#8220;But that&#8217;s not what I want out of life.&#8221;
See Also: Unlock the hidden potential of commercial real estate —<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a>
<h2 class="wp-block-heading">Humility And A Modest Lifestyle</h2>
The Carters were not flashy people, eating Saturday night dinners on paper plates with neighbors and showing up to a local <a href="https://www.benzinga.com/24/12/42371935/dollar-general-faces-mixed-analyst-views-following-q3-back-to-basics-strategy-impacted-by-competitive-pressures">Dollar General</a> store opening where he bought clothes, according to a 2011 Rolling Stone article. Despite his humble lifestyle, Carter, according to Celebrity Net Worth, was worth $10 million at the time of his death, which is a sizable sum compared to most Americans but modest compared to other American Presidents.&nbsp;
During his presidency, Carter earned $200,000 a year as a salary – the standard at the time (presidents currently earn $400,000 annually). In addition, as a former President, Carter earned a pension of $207,800 a year, plus $150,000 a year for staff like his Secret Service protection. All ex-presidents are given allowances for expenses like travel and office space. In 2024, Carter received around $118,000 in such allowances, according to the National Taxpayers Union Foundation, a conservative advocacy group.
Carter&#8217;s lifestyle differs markedly from that of other recent presidents, most obviously from Donald Trump, whose 17-acre home in Palm Beach&#8217;s Mar-a-Lago was estimated by Forbes to be worth $325 million in 2023.
Trending: <a href="https://www.benzinga.com/money/arrived-centennial">Jeff Bezos-Backed Arrived Homes Hits A Big Sale On Charlotte Property – Investors Earning A 34.7% Return</a>
<h2 class="wp-block-heading">Post-Presidency Wealth</h2>
Former presidents are not immune to the financial trappings that being the leader of the free world affords. Soon after Barack Obama left office, he purchased a mansion worth $8.1 million in Washington. This was reportedly followed by a 2019 purchase of a nearly $12 million estate on the Massachusetts island of Martha&#8217;s Vineyard and a lucrative multiyear deal – as described by Billboard – with Amazon-owned audiobook and podcast service Audible.
As<a href="https://www.vox.com/culture/2017/3/2/14779892/barack-michelle-obama-65-million-book-deal-penguin-random-house"> Vox</a> and many other outlets reported, the Obamas also received a $65 million advance for their memoirs. In addition, the high-voltage couple signed a deal to produce shows with Netflix – thought to be in the tens of millions – as reported by Deadline, many of which have already been big hits.
Trending: Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a>
According to Forbes, Joe Biden reportedly has a net worth of $10 million, while Bill and Hillary Rodham Clinton have a combined net worth of $120 million. Very little of that is in real estate, however. The famous couple owns a home in Chappaqua, New York, purchased in 1999 for $1.7 million and the next-door property they reportedly bought in 2016 for $1.1 million. They also own a home in D.C., purchased for $2.85 million in 2000.&nbsp;
According to CBS, former President George Bush – who earned $15 million in his first two years out of office on the speaking circuit – owns a 1,600-acre ranch in Crawford, Texas and a four-bedroom home in<a href="https://www.benzinga.com/real-estate/24/09/40796590/dallas-home-prices-return-to-pre-pandemic-levels-as-inventory-skyrockets-what-it-means-for-buyers"> Dallas</a>, valued at $2.5 million, according to public property records.&nbsp;
Carter&#8217;s attitude toward money is best shown by the quote, &#8220;We give money, we don&#8217;t take it,&#8221; which the late president told The Los Angeles Times in 1989. Though he only served one term, his humanitarian legacy and humility will endure for generations.
Read Next:
<ul>
<li>Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a></li>
<li><a href="https://www.benzinga.com/money/arrived-private-credit-fund">Bezos' Favorite Real Estate Platform Launches A Way To Ride The Ongoing Private Credit Boom</a></li>
</ul>

Real Estate

Former President Jimmy Carter Spent His Last 43 Years Living In A $167,000 House. Here's A Look At The Homes Of Recent Past Presidents

T-Mobile US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) has outperformed the market over the past 10 years by 10.74% on an annualized basis producing an average annual return of 21.92%. Currently, T-Mobile US has a market capitalization of $248.84 billion. 
Buying $1000 In TMUS: If an investor had bought $1000 of TMUS stock 10 years ago, it would be worth $7,258.97 today based on a price of $214.43 for TMUS at the time of writing.
<h3>T-Mobile US's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736869508_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

TMUS

Here's How Much You Would Have Made Owning T-Mobile US Stock In The Last 10 Years

SNOW

Snowflake shares are trading higher on possible continued strength after Oppenheimer raised its price target on the stock from $180 to $200 on Monday.

Wells Fargo analyst Sam Reid maintains KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) with a Underweight and raises the price target from $65 to $70.

Wells Fargo Maintains Underweight on KB Home, Raises Price Target to $70

GE Vernova shares are trading higher after JP Morgan and B of A Securities raised their respective price targets on the stock.

Regeneron Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) CEO and founder Leonard Schleifer highlighted the company&#8217;s product pipeline during <a href="https://www.benzinga.com/general/health-care">JPMorgan&#8217;s Healthcare Conference on Monday</a>.
<h2 class="wp-block-heading">EYLEA</h2>
<ul>
<li>In 2024, EYLEA HD (8 mg) and EYLEA (2 mg) achieved $6 billion in total annual sales and $1.5 billion in fourth-quarter sales <a href="https://www.benzinga.com/pressreleases/25/01/g42940182/regeneron-provides-business-updates-and-highlights-from-broad-clinical-pipeline-at-the-43rd-annual" target="_blank" rel="noreferrer noopener">despite growing competition</a>.</li>
<li>The company applied for FDA approval of an EYLEA HD pre-filled syringe, with a decision and launch expected by mid-2025.</li>
<li>The FDA is reviewing data for wet age-related macular degeneration and diabetic macular edema, potentially extending EYLEA HD dosing to every 24 weeks. A decision (PDUFA date) is expected by April 20, 2025.</li>
<li>A submission for FDA approval of EYLEA HD for four-week dosing and retinal vein occlusion is planned for early 2025 to expand treatment options.</li>
</ul>
<h2 class="wp-block-heading">Libtayo</h2>
<ul>
<li>Libtayo&nbsp;(cemiplimab) <a href="https://investor.regeneron.com/static-files/f5556fde-092a-4792-ae53-161550abd551" target="_blank" rel="noreferrer noopener">exceeded</a> $1 billion in sales for 2024 and remains foundational to Regeneron&#8217;s oncology portfolio.</li>
<li>Regeneron released results from the Phase 3 C-POST trial, which demonstrated that adjuvant treatment with Libtayo&nbsp;led to a statistically significant and clinically meaningful improvement in the primary endpoint of disease-free survival in patients with high-risk cutaneous squamous cell <a href="https://www.benzinga.com/pressreleases/25/01/g42939800/adjuvant-libtayo-cemiplimab-significantly-improves-disease-free-survival-dfs-after-surgery-in-high" target="_blank" rel="noreferrer noopener">carcinoma after surgery</a>.</li>
<li>At the first prespecified interim analysis, Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death compared to placebo.</li>
</ul>
<h2 class="wp-block-heading">Dupixent</h2>
<ul>
<li>Dupixent&nbsp;(dupilumab) is now used to treat over a million patients globally. The recent approval and launch in chronic obstructive pulmonary disease (COPD) have had a successful start, with coverage secured from the top commercial and Medicare payers. Dupixent is now well-positioned to address approximately 300,000 patients in the U.S.</li>
<li>In the third quarter of 2024, Dupixent&#8217;s global net sales reached $3.8 billion (+23% YoY), annualizing over $15 billion.</li>
</ul>
Regeneron&#8217;s total addressable commercial market is expected to exceed $220 billion by 2030. Some near-term highlights include:
<ul>
<li>Itepekimab (IL-33) for COPD:&nbsp;Results are expected from the Phase 3 AERIFY study in the second half of 2025, with a potential BLA submission to follow.</li>
<li>Fianlimab (LAG3) for melanoma: Combining fianlimab and Libtayo in Phase 3 trial. Data is expected in the second half of 2025</li>
<li>Linvoseltamab (BCMAxCD3) for multiple myeloma:&nbsp;A BLA has been resubmitted following the resolution of third-party manufacturing issues, with launch anticipated in mid-2025.</li>
<li>Odronextamab (CD20xCD3) for lymphoma: Enrollment is underway for a confirmatory study to support resubmission of the BLA for FL to the FDA in the first quarter of 2025.</li>
<li>Factor XI for anticoagulation:&nbsp;Two Factor XI antibodies, REGN7508 (catalytic domain) and REGN9933 (A2 domain), will advance to pivotal trials in 2025.</li>
<li>Multiple approaches to obesity:&nbsp;Regeneron is studying various combinations with GLP-based therapies. A Phase 2 study of trevogrumab and semaglutide with and without garetosmab is now fully enrolled and a Phase 2 study testing combinations of tirzepatide and mibavademab is ongoing, with initial data expected from both in the second half of 2025.</li>
<li>BCMAxCD3/Dupixent in severe allergy: Combining linvoseltamab and Dupixent can potentially eliminate immunoglobulin E (IgE), the key driver of allergic reactions, and thus potentially reverse severe allergies. A trial in patients with severe food allergies is ongoing, with initial clinical data showing a profound reduction of IgE in the first patient treated.</li>
<li>C5 Combo (pozelimab and cemdisiran) in complement-mediated diseases:&nbsp;Phase 3 data for generalized myasthenia gravis expected in the second half of 2025. Phase 3 data from paroxysmal nocturnal hemoglobinuria expected in 2026+ and geographic atrophy, a Phase 3 trial in an advanced form of dry AMD is underway.</li>
</ul>
Price Action: Regeneron stock is down 1.23% at $708.05 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/contracts/25/01/42974467/jacobs-solutions-stock-rises-on-securing-key-role-in-dublins-busconnects" target="_blank" rel="noreferrer noopener">Jacobs Solutions&#8217; Stock Rises On Securing Key Role In Dublin&#8217;s BusConnects</a></li>
</ul>

Biotech

Large Cap

Health Care

General

REGN

Regeneron Pipeline Aims To Address $220 Billion Therapeutic Opportunities By 2030

Truist Securities analyst Joon Lee reiterates argenx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) with a Buy and raises the price target from $660 to $700.

Reiteration

ARGX

Truist Securities Reiterates Buy on argenx, Raises Price Target to $700

Wells Fargo analyst Elyse Greenspan maintains RenaissanceRe Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>) with a Overweight and lowers the price target from $301 to $288.

Wells Fargo Maintains Overweight on RenaissanceRe Holdings, Lowers Price Target to $288

CHGG

Chegg shares are trading lower after Morgan Stanley downgraded the stock from Equal-Weight to Underweight and cut its price target from $2 to $1.25.

Truist Securities analyst Michael Ciarmoli maintains Woodward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) with a Buy and raises the price target from $226 to $229.

Truist Securities Maintains Buy on Woodward, Raises Price Target to $229

XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) is seeing its stock rise on Tuesday, in line with a broader uptick in Chinese stocks, following reports that China&#8217;s central bank plans to implement <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">measures to support economic growth.</a>
Meanwhile, the leading Chinese electric vehicle manufacturer has reportedly announced a new deal with BP Pulse, the EV charging arm of British oil giant BP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>), CnEV Post <a target="_blank" href="https://cnevpost.com/2025/01/14/xpeng-bp-pulse-share-charging-network-china/" rel="noreferrer noopener">reports</a>.
Under the terms of the memorandum of understanding, both companies will share their respective charging networks, allowing customers to access over 30,000 charging stations spread across 420 cities in China.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, XPEV stock has gained about 19% in the past year.
Investors can gain exposure to the stock via&nbsp;VanEck Low Carbon Energy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMOG#NYSE">SMOG</a>).
This partnership follows XPeng&#8217;s <a target="_blank" href="https://www.benzinga.com//node/42807958" rel="noreferrer noopener">previous collaboration </a>with Volkswagen AG, further enhancing the company&#8217;s charging infrastructure.
Also Read: <a target="_blank" href="https://www.benzinga.com/tech/25/01/42967935/tsla-stock-rises-3-in-tuesday-pre-market-whats-going-on" rel="noreferrer noopener">TSLA Stock Rises 3% In Tuesday Pre Market: What&#8217;s Going On?</a>
Additionally, XPeng recently previewed&nbsp;its G7 SUV, aimed at competing in the <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/01/42909377/whats-going-on-with-xpeng-stock-on-friday-2" rel="noreferrer noopener">RMB250,000 ($34,100) market segment.</a>
The G7, designed with family users in mind, offers ample space and advanced AI features, making it a strong contender in the Chinese EV market.
XPeng also made news recently by selecting RTI Connext Drive as the core communication technology for its next-generation vehicle architecture, <a target="_blank" href="https://www.benzinga.com//node/42820858" rel="noreferrer noopener">starting with 2026 models.</a>
This technology will enhance data management and drive smarter, more efficient designs for XPeng&#8217;s future cars.
Price Action: XPEV stock is trading higher by 7.43% to $12.69 at last check Tuesday.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/25/01/42960104/congressman-who-wanted-airport-named-after-donald-trump-buys-bitcoin-solana-xrp-token-ahead-of-inauguration" target="_blank" rel="noreferrer noopener">Congressman Who Wanted Airport Named After Trump Buys Bitcoin, Solana, XRP Token Ahead Of Inauguration</a></li>
</ul>
Photo by Koshiro K on Shutterstock.

Equities

Markets

Movers

Media

SMOG

VWAGY

XPEV

XPeng Teams Up With BP Pulse To Expand EV Charging Network Across China: Report

Wells Fargo analyst Elyse Greenspan maintains Everest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EG#NYSE">EG</a>) with a Equal-Weight and lowers the price target from $390 to $380.

Wells Fargo Maintains Equal-Weight on Everest Group, Lowers Price Target to $380

Truist Securities analyst Michael Ciarmoli maintains VSE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSEC#NASDAQ">VSEC</a>) with a Buy and lowers the price target from $133 to $129.

VSEC

Truist Securities Maintains Buy on VSE, Lowers Price Target to $129

Truist Securities analyst Michael Ciarmoli maintains Triumph Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGI#NYSE">TGI</a>) with a Hold and raises the price target from $18 to $19.

Truist Securities Maintains Hold on Triumph Group, Raises Price Target to $19

Wells Fargo analyst Elyse Greenspan maintains Allstate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>) with a Equal-Weight and raises the price target from $186 to $187.

Wells Fargo Maintains Equal-Weight on Allstate, Raises Price Target to $187

Wells Fargo analyst Elyse Greenspan maintains Root (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) with a Equal-Weight and raises the price target from $78 to $80.

Comments

West Vault Mining

News

Latest news for West Vault Mining (OTC:WVMDF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga